Molecular markers in glioma
K Ludwig, HI Kornblum - Journal of neuro-oncology, 2017 - Springer
Gliomas are the most malignant and aggressive form of brain tumors, and account for the
majority of brain cancer related deaths. Malignant gliomas, including glioblastoma are …
majority of brain cancer related deaths. Malignant gliomas, including glioblastoma are …
Podoplanin in inflammation and cancer
M Quintanilla, L Montero-Montero, J Renart… - International journal of …, 2019 - mdpi.com
Podoplanin is a small cell-surface mucin-like glycoprotein that plays a crucial role in the
development of the alveoli, heart, and lymphatic vascular system. Emerging evidence …
development of the alveoli, heart, and lymphatic vascular system. Emerging evidence …
A tension-mediated glycocalyx–integrin feedback loop promotes mesenchymal-like glioblastoma
Glioblastoma multiforme (GBMs) are recurrent lethal brain tumours. Recurrent GBMs often
exhibit mesenchymal, stem-like phenotypes that could explain their resistance to therapy …
exhibit mesenchymal, stem-like phenotypes that could explain their resistance to therapy …
[HTML][HTML] The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma
W Huang, Z Zhong, C Luo, Y Xiao, L Li, X Zhang… - Theranostics, 2019 - ncbi.nlm.nih.gov
Aberrant expression of transcription factor AP-2α has been functionally associated with
various cancers, but its clinical significance and molecular mechanisms in human glioma …
various cancers, but its clinical significance and molecular mechanisms in human glioma …
Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
B England, T Huang, M Karsy - Tumor Biology, 2013 - Springer
Glioblastoma multiforme (GBM) is the most common primary malignancy in the brain and
confers a uniformly poor prognosis. Despite decades of research on the topic, limited …
confers a uniformly poor prognosis. Despite decades of research on the topic, limited …
Glioblastoma: molecular pathways, stem cells and therapeutic targets
M Jhanwar-Uniyal, M Labagnara, M Friedman… - Cancers, 2015 - mdpi.com
Glioblastoma (GBM), a WHO-defined Grade IV astrocytoma, is the most common and
aggressive CNS malignancy. Despite current treatment modalities, the survival time remains …
aggressive CNS malignancy. Despite current treatment modalities, the survival time remains …
The emerging roles of Oct4 in tumor-initiating cells
YJ Wang, M Herlyn - American Journal of Physiology-Cell …, 2015 - journals.physiology.org
Octamer-binding transcription factor 4 (Oct4), a homeodomain transcription factor, is well
established as a master factor controlling the self-renewal and pluripotency of pluripotent …
established as a master factor controlling the self-renewal and pluripotency of pluripotent …
The EGF receptor promotes the malignant potential of glioma by regulating amino acid transport system xc (—)
K Tsuchihashi, S Okazaki, M Ohmura, M Ishikawa… - Cancer research, 2016 - AACR
Extracellular free amino acids contribute to the interaction between a tumor and its
microenvironment through effects on cellular metabolism and malignant behavior. System xc …
microenvironment through effects on cellular metabolism and malignant behavior. System xc …
Notching on cancer's door: Notch signaling in brain tumors
M Teodorczyk, MHH Schmidt - Frontiers in oncology, 2015 - frontiersin.org
Notch receptors play an essential role in the regulation of central cellular processes during
embryonic and postnatal development. The mammalian genome encodes for four Notch …
embryonic and postnatal development. The mammalian genome encodes for four Notch …
Mouse models of glioma
SS Stylli, RB Luwor, TMB Ware, F Tan… - Journal of Clinical …, 2015 - Elsevier
Gliomas are the most common primary tumour in the central nervous system in adults. The
pathological hallmark of gliomas is their propensity for extensive infiltration into the …
pathological hallmark of gliomas is their propensity for extensive infiltration into the …